Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Ecopipam hydrochloride (HCl) is an investigational drug being studied for several possible
diseases. To date, all clinical studies have been done using the ecopipam immediate release
(IR) tablet. However, a controlled release (CR) capsule formulation of ecopipam has been
produced that may be able to improve its effectiveness and reduce its side effects. The main
purpose of this study is to evaluate the safety and tolerability of ecopipam CR capsules when
given as single oral dose in healthy volunteers.